HCPLive

Rheumatology

Many patients with rheumatoid arthritis aren't receiving the much-needed, low-cost medications that can prevent deformity.
Scientists have discovered naturally present anti-inflammatory steroids in humans.
Experimental drug PLX5622 has been shown in preclinical arthritis models to reduce inflammation, reduce cartilage damage, and prevent bone resorption.
Common rheumatoid arthritis drug receives FDA approval to treat certain follicular lymphoma patients.
By using hand-held PDA devices, fibromyalgia patients and their doctors receive further insight into pain and the complex disease.
The later the onset of puberty, the lower an adolescent's bone mass, increasing their risk of developing osteoporosis later in life.
Researchers in China have demonstrated interferon-alpha is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus.
USPSTF revised recommendations for managing osteoporosis call for screening women age 65 and older and younger women at increased risk for fractures.
A three-month study reveals Fostamatinib is most-effective with specific subset of rheumatoid arthritis patients, but not others.
Low socioeconomic status (SES) is associated with higher risk of depressive symptoms in patients with rheumatoid arthritis.
NICE, the UK-based institute, published an updated final guidance on osteoporosis fractures prompted by an appeal regarding strontium ranelate.
Could your knee pain be related to flat feet?
Physicians from the Medical University of South Carolina discuss bone health.
The American College of Rheumatology has updated its recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
Fat associates with distinctive chemical changes in DNA, shedding light on why obesity increases risk for diabetes and other chronic problems.
Read about some of the latest research studies on fibromyalgia.
Dr. Steven Haddad discusses the main differences between ankle anthropasty and ankle fusion surgery.
People with osteoarthritis are more likely to be able to walk quickly if they lead physically active lives.
Scientists from the Monell Center studying the receptor TRPA1 find it is activated by both chemicals.
A company receives a US patent for a method that desensitizes B cells, which may curb autoimmune diseases.
Sign up for HCPLive eNewsletters
*Firstname:
*Lastname:
*Email:
*Practice Type:

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
 




Become a Member